CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1a/1b Study of COM701 as Monotherapy and In Combination With an Anti-PD-1 Antibody in Subjects With Advanced Solid Tumors.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03667716
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:57.946230+00:00
Published At: 2025-01-17T00:00:00+00:00
Record Updated At: 2025-01-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Cancer", "Ovarian Cancer", "Breast Cancer", "Lung Cancer", "Endometrial Cancer", "Ovarian Neoplasm", "Triple Negative Breast Cancer", "Lung Neoplasm", "Neoplasm Malignant", "Colo-rectal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-17"
protocolSection.identificationModule.nctId: "NCT03667716"
protocolSection.identificationModule.officialTitle: "A Phase 1a/1b Study of COM701 as Monotherapy and In Combination With an Anti-PD-1 Antibody in Subjects With Advanced Solid Tumors."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.